Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

NCT04223583 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT04223583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04223583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule
Lead sponsor
Henan Cancer Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 26, 2019
Completion date
April 30, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcomas